Timeline: When Bad Research Changes Public Health Strategy

Illinois-based Surgisphere Corporation had a brief moment in the limelight this year following its infamous study of hydroxychloroquine. But the impact of the company’s deception reverberated across world.

Catherine Offord

Oct 1, 2020 | 1 min read

ABOVE: © ISTOCK.COM, BORISLAV; © ISTOCK.COM, EDEVARDE_MOREIRA; WIKIMEDIA, THE WORLD HEALTH ORGANIZATION

Surgisphere Corporation had a busy few months in 2020, overseeing the launch of a new website, the publication of high-impact papers on treatments and outcomes in COVID-19 patients, and eventually a collapse of its reputation.

Read the full story.

More Articles in microbiology

Cross section of an organic cell with intracellular organelles

How Intracellular Bacteria Hijack Your Cells

Illustration showing how some intracellular bacteria, such as <em >Legionella pneumophila</em>, manipulate the cell's membranes for their own good

Infographic: Intracellular Bacteria’s Tricks for Host Manipulation

Image of a white cardboard box with a blue vertical stripe on the left side, the word “Apixaban” in blue lettering at the bottom, and a depiction of apixaban’s molecular structure in black.

Blood Thinner Ineffective for COVID-19 Patients: Study

close-up photo of fruit fly on white background

Scientists ID Heart-Damaging SARS-CoV-2 Protein